Integrative neuroscience approach to predict ADHD stimulant response

References

• Faraone SV, Biederman J, Spencer T et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol. Psychiatry48, 9–20 (2000).
   PubMed Web of Science ®Google Scholar
• Bussing R, Schoenberg NE, Perwien AR. Knowledge and information about ADHD: evidence of cultural differences among African–American and white parents. Social Sci. Med.46, 919–928 (1998).
   PubMed Web of Science ®Google Scholar
• Bradley JD, Golden CJ. Biological contributions to the presentation and understanding of attention-deficit/hyperactivity disorder: a review. Clin. Psychology Rev.21, 907–929 (2001).
   PubMed Web of Science ®Google Scholar
• Niedermeyer E, Naidu SB. Attention-deficit hyperactivity disorder (ADHD) and frontal-motor cortex disconnection. Clin. Electroencephalogr.28, 130–136 (1997).
   PubMedGoogle Scholar
• Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry44, 951–958 (1998).
   PubMed Web of Science ®Google Scholar
• Guevara J, Lozano P, Wickizer T et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics108, 71–78 (2001).
   PubMed Web of Science ®Google Scholar
• Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J. Am. Acad. Child Adolesc. Psychiatry36, 1065–1079 (1997).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (4th Edition). American Psychiatric Press, Washington, DC, USA (1994).
   Google Scholar
• Lazzaro I et al. Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder. Int. J. Psychophysiol.34, 123–134 (1999).
   PubMed Web of Science ®Google Scholar
• Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry57, 1273–1284 (2005).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry46, 1234–1242 (1999).
   PubMed Web of Science ®Google Scholar
• Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann. NY Acad. Sci.931, 1–16 (2001).
   PubMed Web of Science ®Google Scholar
• Sagvolden T, Sergeant JA. Attention deficit/hyperactivity disorder-from brain dysfunctions to behavior. Behav. Brain Res.94, 1–10 (1998).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry35, 264–272 (1996).
   PubMed Web of Science ®Google Scholar
• Sawyer MG, Arney FM, Baghurst PA et al. The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being. Aust. NZ J. Psychiatry35, 806–814 (2001).
   PubMed Web of Science ®Google Scholar
• Benjasuwantep B, Ruangdaraganon N, Visudhiphan P. Prevalence and clinical characteristics of attention deficit hyperactivity disorder among primary school students in Bangkok. J. Med. Assoc. Thai.85(Suppl. 4) S1232–S1240 (2002).
   PubMedGoogle Scholar
• Gallucci F, Bird HR, Berardi C et al. Symptoms of attention-deficit hyperactivity disorder in an Italian school sample: findings of a pilot study. J. Am. Acad. Child Adolesc. Psychiatry32, 1051–1058 (1993).
   PubMed Web of Science ®Google Scholar
• Guardiola A, Fuchs FD, Rotta NT. Prevalence of attention-deficit hyperactivity disorders in students. Comparison between DSM-IV and neuropsychological criteria. Arq. Neuropsiquiatr.58, 401–407 (2000).
   PubMedGoogle Scholar
• Kanbayashi Y, Nakata Y, Fujii K et al. ADHD-related behavior among non-referred children: parents' ratings of DSM-III-R symptoms. Child Psychiatry Hum. Dev.25, 13–29 (1994).
   PubMed Web of Science ®Google Scholar
• Leung PW, Luk SL, Ho TP et al. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br. J. Psychiatry168, 486–496 (1996).
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay M, Misra S, Mitra T et al. Attention deficit hyperactivity disorder. Indian J. Pediatr.70, 789–792 (2003).
   PubMedGoogle Scholar
• Pineda DA, Lopera F, Palacio JD et al. Prevalence estimations of attention-deficit/hyperactivity disorder: differential diagnoses and comorbidities in a Colombian sample. Int. J. Neurosci.113, 49–71 (2003).
   PubMed Web of Science ®Google Scholar
• Rohde LA, Biederman J, Busnello EA et al. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J. Am. Acad. Child Adolesc. Psychiatry38, 716–722 (1999).
   PubMed Web of Science ®Google Scholar
• Scholte EM, Berckelaer-Onnes IA, van der Ploeg JD. Factorial validity, reliability of assessments and prevalence of ADHD behavioral symptoms in day and residential treatment centres for children with behavioral problems. Int. J. Methods Psychiatr. Res.11, 33–44 (2002).
   PubMedGoogle Scholar
• Wang YC, Chong MY, Chou WJ et al. Prevalence of attention deficit hyperactivity disorder in primary school children in Taiwan. J. Formos. Med. Assoc.92, 133–138 (1993).
   PubMedGoogle Scholar
• Burd L, Klug MG, Coumbe MJ et al. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. J. Child Neurol.18, 555–561 (2003).
   PubMed Web of Science ®Google Scholar
• Lesesne CA, Visser SN, White CP. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources. Pediatrics111(Pt 7) 1232–1237(2003).
   PubMed Web of Science ®Google Scholar
• Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc. Psychiatr. Clin. N. Am.9, 541–555 (2000).
   PubMed Web of Science ®Google Scholar
• Ford T, Goodman R, Meltzer H. The british child and adolescent mental health survey 1999: the prevalence of DSM-IV disorders. J. Am. Acad. Child Adolesc. Psychiatry42, 1203–1211 (2003).
   PubMed Web of Science ®Google Scholar
• Parr JR, Ward A, Inman S. Current practice in the management of attention deficit disorder with hyperactivity (ADHD). Child Care Health Dev.29, 215–218 (2003).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Mick E et al. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources, J. Am. Acad. Child Adolesc. Psychiatry38, 966–975 (1999).
   PubMed Web of Science ®Google Scholar
• Paule MG, Swanson JM, Castellanos FX et al. Attention deficit/hyperactivity disorder: characteristics, interventions and models. Neurotoxicol. Teratol.22, 631–651 (2000).
   PubMedGoogle Scholar
• Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment. Retard. Dev. Disabil. Res. Rev.8, 162–170 (2002).
   PubMedGoogle Scholar
• Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J. Am. Acad. Child Adolesc. Psychiatry36(Suppl.) 85–121 (1997).
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am. J. Psychiatry157, 816–818 (2000).
   PubMed Web of Science ®Google Scholar
• Searight HR, Burke JM, Rottnek F. Adult ADHD: evaluation and treatment in family medicine. American Family Physician62, 2077–2086 (2000).
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Biederman J, Weber W et al. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol. Psychiatry44, 260–268 (1998).
   PubMed Web of Science ®Google Scholar
• Conrad P, Potter D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Social Problems47, 559–582 (2000).
   Web of Science ®Google Scholar
• Arnold LE. Sex differences in ADHD: conference summary. J. Abnorm. Child Psychol.24, 555–569 (1996).
   PubMed Web of Science ®Google Scholar
• Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J. Am. Acad. Child Adolesc. Psychiatry36, 1036–1045 (1997).
   PubMed Web of Science ®Google Scholar
• Arcia E, Conners CK. Gender differences in ADHD? J. Dev. Behav. Pediatr.19, 77–83 (1998).
   PubMed Web of Science ®Google Scholar
• De Quiros GB, Palmer D, Tocci R et al. Attention deficit disorder in children: three clinical variants. J. Dev. Behav. Pediatr.15, 311–319 (1994).
   PubMedGoogle Scholar
• Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J. Clin. Psychiatr.59(Suppl.16), 41–46 (1998).
   Google Scholar
• Satterfield JH, Cantwell DP, Satterfield BT. Pathophysiology of the hyperactive child syndrome. Arch. Gen. Psychiatry31, 839–844 (1974).
   PubMed Web of Science ®Google Scholar
• Satterfield JH, Cantwell DP. Proceedings: CNS function and response to methylphenidate in hyperactive children. Psychopharmacol. Bull.10, 36–37 (1974).
   PubMedGoogle Scholar
• Rapoport JL, Inoff-Germain G. Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: update 2002. J. Atten. Disord.6(Suppl. 60) (2002).
   Google Scholar
• Callaway E, Halliday R, Naylor H. Hyperactive children’s event-related potentials fail to support underarousal and maturational-lag theories. Arch. Gen. Psychiatry40, 1243–1248 (1983).
   PubMed Web of Science ®Google Scholar
• Vaidya CJ, Austin G, Kirkorian G et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl Acad. Sci. USA95, 14494–14499 (1998).
   PubMed Web of Science ®Google Scholar
• Pliszka SR. Non-stimulant treatment of attention-deficit/hyperactivity disorder. CNS Spectrums8, 253–258 (2003).
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry41, 26S–49S (2002).
   PubMed Web of Science ®Google Scholar
• Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics100, 662–666 (1997).
   PubMed Web of Science ®Google Scholar
• Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparison. Med. J. Aust.177, 539–543 (2002).
   PubMed Web of Science ®Google Scholar
• Sawyer MG, Rey JM, Graetz BW et al. Use of medication by young people with attention-deficit/hyperactivity disorder. Med. J. Aust.177, 21–25 (2002).
   PubMed Web of Science ®Google Scholar
• Jensen PS, Kettle L, Roper MT et al. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J. Am. Acad. Child Adolesc. Psychiatry38, 797–804 (1999).
   PubMed Web of Science ®Google Scholar
• Angold A, Erkanli A, Egger HC et al. Stimulant treatment for children: a community perspective. J. Am. Acad. Child Adolesc. Psychiatry39, 975–984 (2000).
   PubMed Web of Science ®Google Scholar
• Prosser B, Reid R. Psychostimulant use for children with ADHD in Australia. J. Emot. Behav. Disord.7, 110–117 (1999).
   Web of Science ®Google Scholar
• Robison LM, Sclar DA, Skaer TL et al. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990–1995. Clin. Pediatr.38, 209–217 (1999).
   PubMed Web of Science ®Google Scholar
• Vitiello B, Jensen PS. Medication development and testing in children and adolescents. Current problems, future directions. Arch. Gen. Psychiatry54, 871–976 (1997).
   PubMedGoogle Scholar
• Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics98, 1084–1088 (1996).
   PubMed Web of Science ®Google Scholar
• Greydanus DE, Sloane MA, Rappley MD. Psychopharmacology of ADHD in adolescents. Adolesc. Med.13, 599–624 (2002).
   PubMedGoogle Scholar
• Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Beh. Brain Res.94, 127–152 (1998).
   PubMed Web of Science ®Google Scholar
• Young ES, Perros P, Price GW et al. Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder. Biol. Psychiatry37, 25–33 (1995).
   PubMed Web of Science ®Google Scholar
• Greenhill L, Beyer DH, Finkleson J et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit hyperactivity disorder. J. Atten. Disord.6, 89–100 (2002).
   PubMedGoogle Scholar
• Perrin JM, Stein MT, Amler RW et al. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108, 1033–1044 (2001).
   PubMedGoogle Scholar
• Hood J, Baird G, Rankin PM et al. Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder. Dev. Med. Child Neurol.47, 408–414 (2005).
   PubMed Web of Science ®Google Scholar
• Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J. Child Psychol. Psychiatry45(2), 293–305 (2004).
   PubMed Web of Science ®Google Scholar
• Kempton S, Vance ALA, Maruff P et al. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol. Med.29, 527–538 (1999).
   PubMed Web of Science ®Google Scholar
• Chelonis JJ, Edwards MC, Schulz EG et al. Stimulant medication improves recognition memory in children diagnosed with attention-deficit/hyperactivity disorder. Exp. Clin. Psychopharmacol.10, 400–407 (2002).
   PubMedGoogle Scholar
• Sunohara GA, Malone MA, Rovet J et al. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacol.21, 218–228 (1999).
   PubMed Web of Science ®Google Scholar
• Arnold LE, Christopher J, Huestis R et al. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arch. Gen. Psychiatry35, 463–473 (1978).
   PubMed Web of Science ®Google Scholar
• Elia J, Borcherding BG, Potter WZ et al. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res.36, 141–155 (1991).
   PubMed Web of Science ®Google Scholar
• Barkley RA. Predicting the response of hyperkinetic children to stimulant drugs: a review. J. Abnorm. Child Psychol.4, 327–348 (1976).
   PubMed Web of Science ®Google Scholar
• Arnold LE. Methlyphenidate vs. amphetamine: comparative review. J. Att. Dis.3, 200–211 (2000).
   Google Scholar
• Gray JR, Kagan J. The challenge of predicting which children with attention deficit-hyperactivity disorder will respond positively to methylphenidate. J. Appl. Dev. Psychol.21, 471–489 (2000).
   Web of Science ®Google Scholar
• Perrin JM, Stein MT, Amler RW et al. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108, 1033–1044 (2001).
   PubMedGoogle Scholar
• Riccio CA, Waldrop J, Reynolds C et al. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J. Neuropsychiatry Clin. Neurosci.13, 326–335 (2001).
   PubMed Web of Science ®Google Scholar
• Seifert J, Scheuerpflug P, Zillessen KE et al. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J. Neural Transm.110, 821–829 (2003).
   PubMed Web of Science ®Google Scholar
• Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J. Am. Acad. Child Adolesc. Psychiatry26, 676–686 (1987).
   PubMed Web of Science ®Google Scholar
• Denney CB, Rapport MD. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models. J. Am. Acad. Child Adolesc. Psychiatry38, 393–401 (1999).
   PubMed Web of Science ®Google Scholar
• Conners CK. The effect of stimulant drugs on human figure drawings in children with minimal brain dysfunction. Psychopharmacologia19, 329–333 (1971).
   PubMed Web of Science ®Google Scholar
• Conners CK. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Pediatrics49, 702–708 (1972).
   PubMed Web of Science ®Google Scholar
• Thomson JB, Varley CK. Prediction of stimulant response in children with attention-deficit/hyperactivity disorder. J. Child Adol. Psychopharmacol.8, 125–132 (1998).
   PubMed Web of Science ®Google Scholar
• Zeiner P, Bryhn G, Bjercke C et al. Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta Paediatr.88, 298–303 (1999).
   PubMed Web of Science ®Google Scholar
• Denney CB, Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues. J. Clin. Child Psychol.30, 98–109 (2001).
   PubMed Web of Science ®Google Scholar
• Saletu B, Anderer P, Kinsperger K et al. Topographic brain mapping of EEG in neuropsychopharmacology–part II. Clinical applications (pharmaco EEG imaging). Methods Find. Exp. Clin. Pharmacol.9, 385–408 (1987).
   PubMed Web of Science ®Google Scholar
• Chabot RJ, Orgill AA, Crawford G et al. Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. J. Child Neurol.14, 343–351 (1999).
   PubMed Web of Science ®Google Scholar
• Sangal RB, Sangal JM. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate. Clin. Neurophysiol.115, 188–193 (2004).
   PubMedGoogle Scholar
• Sangal RB, Sangal JM. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine. Clin. Neurophysiol.116, 640–647 (2005).
   PubMed Web of Science ®Google Scholar
• Conners CK. Review of stimulant drugs in learning and behavior disorders. Psychopharmacol. Bull.7, 39–40 (1971).
   PubMedGoogle Scholar
• Gordon E, Cooper N, Rennie C, Hermens D et al. Integrative neuroscience: the role of a standardized database. Clin. EEG Neurosci.36, 64–75 (2005).
   PubMed Web of Science ®Google Scholar
• Hermens DF, Cooper NJ, Kohn M et al. Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J. Integr. Neurosci.4, 107–121 (2005).
   PubMedGoogle Scholar
• Paul RH, Lawrence J, Williams LM et al. The validity of ‘integneuro’: a new computerized and standardized battery of neurocognitive tests. Int. J. Neurosci.115, 1549–1567 (2005).
   PubMed Web of Science ®Google Scholar
• Williams LM, Simms E, Clark CR et al. The test-retest reliability of a standardized psychophysiological and neuropsychological test battery: 'NeuroMarker'. Int. J. Neurosci.115, 1605–1630 (2005).
   PubMed Web of Science ®Google Scholar
• Johnstone J, Gunkelman J, Lunt J. Clinical database development: characterization of EEG phenotypes. Clin. EEG Neurosci.36, 99–107 (2005).
   PubMed Web of Science ®Google Scholar